Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CenteneMEX:CNC -4.54%72 Piotroski F-Score is 5 as of Jul. 31, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates MEX:CNC with a GF Score™ of 72/100 and a GF Value™ of MXN1,363.46 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 18 Healthcare Plans companies, Centene ranks worse than 55.56% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Centene has an F-score of 4 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Centene's Piotroski F-Score or its related term are showing as below:
MEX:CNC'
s Piotroski F-Score Range Over the Past 10 Years
Min: 2 Med: 6 Max: 9
Current: 5
During the past 13 years, the highest Piotroski F-Score of Centene was 9. The lowest was 2. And the median was 6.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Centene Piotroski F-Score Related Terms
Centene Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Centene's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:CNC vs HUM, MOH, OSCR: Piotroski F-Score Comparison
For the Healthcare Plans subindustry, Centene's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Centene Piotroski F-Score vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Centene's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Centene's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun26) TTM:
Last Year (Jun25) TTM:
Net Income was -121640.39 + -19824.276 + 27788.391 + 19036.859 = MXN-94,639 Mil. Cash Flow from Operations was 24874.735 + 7868.491 + 78730.768 + 62641.91 = MXN174,116 Mil. Revenue was 911523.298 + 895333.433 + 900625.17 + 934899.971 = MXN3,642,382 Mil. Gross Profit was 59636.994 + 44420.062 + 100225.747 + 80282.849 = MXN284,566 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(1626748.734 + 1505820.346 + 1381883.459 + 1463804.424 + 1448476.388) / 5 = MXN1485346.6702 Mil. Total Assets at the begining of this year (Jun25) was MXN1,626,749 Mil. Long-Term Debt & Capital Lease Obligation was MXN279,707 Mil. Total Current Assets was MXN814,607 Mil. Total Current Liabilities was MXN711,204 Mil.
Net Income was 14039.184 + 5902.163 + 26820.7 + -4763.788 = MXN41,998 Mil.
Revenue was 827445.477 + 851016.838 + 953761.285 + 917772.867 = MXN3,549,996 Mil. Gross Profit was 79450.361 + 77583.204 + 106423.556 + 55489.652 = MXN318,947 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(1523078.404 + 1621515.896 + 1719448.185 + 1780763.562 + 1626748.734) / 5 = MXN1654310.9562 Mil. Total Assets at the begining of last year (Jun24) was MXN1,523,078 Mil. Long-Term Debt & Capital Lease Obligation was MXN330,490 Mil. Total Current Assets was MXN760,493 Mil. Total Current Liabilities was MXN692,651 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Centene's current Net Income (TTM) was -94,639.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Centene's gearing of this year was 0.18831124. Centene's gearing of last year was 0.19977509.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Centene's current ratio of this year was 1.1453912. Centene's current ratio of last year was 1.09794487.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Centene's number of shares in issue this year was 497.637. Centene's number of shares in issue last year was 493.548.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Centene's gross margin of this year was 0.07812625. Centene's gross margin of last year was 0.08984425.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Centene's asset turnover of this year was 2.23905622. Centene's asset turnover of last year was 2.33080349.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
1
+
0
+
1
+
1
+
1
+
0
+
0
+
0
=
4
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Centene has an F-score of 4 indicating the company's financial situation is typical for a stable company.
Centene (MEX:CNC) has a Piotroski F-Score of 5 as of Jul. 31, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Centene and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Centene's Piotroski F-Score has ranged from 2.00 to 9.00. According to the industry distribution chart, Centene ranks #10 out of 18 companies in the Healthcare Plans industry, placing it in the top 55.6%.
Is Centene's Piotroski F-Score too high?
Centene's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 9.00. The Healthcare Plans industry median Piotroski F-Score is 5.50. Centene's value of 5 is 9.1% below this industry median. Based on the distribution chart, Centene ranks #10 out of 18 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Centene has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centene's Piotroski F-Score compare to HUM and MOH?
According to the Healthcare Plans industry distribution chart, Centene ranks #10 out of 18 companies for Piotroski F-Score. This places Centene in the lower half of its industry. The industry median Piotroski F-Score is 5.50. Centene's value of 5 is 9.1% below this benchmark. Historically, Centene's own Piotroski F-Score has ranged from 2.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.50, Centene has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Plans company?
The median Piotroski F-Score among Healthcare Plans companies is 5.50, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Centene's current Piotroski F-Score of 5 is 9.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Centene and its competitors. For the Healthcare Plans industry, the median Piotroski F-Score is 5.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Centene's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centene stock overvalued right now?
Based on GuruFocus' analysis, Centene (MEX:CNC) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,363.46, compared to a current price of MXN1,059.59 — trading 22.3% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 9.1% below the Healthcare Plans industry median of 5.50. Centene's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Centene (MEX:CNC), the current Piotroski F-Score is 5 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Centene (MEX:CNC) Overvalued in 2026?
Based on GuruFocus' analysis, Centene stock appears to be undervalued.
The current stock price of MXN1,059.59 is trading 22.3% below its estimated GF Value™ of MXN1,363.46.
GuruFocus considers Centene to be Modestly Undervalued.
Key valuation signals for MEX:CNC:
Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
GF Value™: MXN1,363.46 vs. price of MXN1,059.59 (22.3% below fair value)
Industry Position: 9.1% below the Healthcare Plans median (#10 of 18)
No single metric tells the full story. See the MEX:CNC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
72GF Score
Get the complete analysis for MEX:CNC
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CNC has been successfully added to your 
